1. Home
  2. ENGN vs MAMA Comparison

ENGN vs MAMA Comparison

Compare ENGN & MAMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo enGene Holdings Inc.

ENGN

enGene Holdings Inc.

HOLD

Current Price

$1.64

Market Cap

115.9M

Sector

N/A

ML Signal

HOLD

Logo Mama's Creations Inc.

MAMA

Mama's Creations Inc.

HOLD

Current Price

$15.15

Market Cap

598.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENGN
MAMA
Founded
1999
2010
Country
Canada
United States
Employees
82
N/A
Industry
Specialty Foods
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
115.9M
598.8M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
ENGN
MAMA
Price
$1.64
$15.15
Analyst Decision
Buy
Strong Buy
Analyst Count
6
5
Target Price
$21.08
$19.00
AVG Volume (30 Days)
3.6M
364.3K
Earning Date
06-11-2026
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
44.44
EPS
N/A
0.13
Revenue
N/A
$95,420,129.00
Revenue This Year
N/A
$31.09
Revenue Next Year
N/A
$16.12
P/E Ratio
N/A
$117.46
Revenue Growth
N/A
95.54
52 Week Low
$1.40
$7.75
52 Week High
$12.25
$17.85

Technical Indicators

Market Signals
Indicator
ENGN
MAMA
Relative Strength Index (RSI) 29.13 56.73
Support Level $1.40 $14.43
Resistance Level $1.87 $16.75
Average True Range (ATR) 0.11 0.65
MACD 0.20 0.09
Stochastic Oscillator 37.84 69.52

Price Performance

Historical Comparison
ENGN
MAMA

About ENGN enGene Holdings Inc.

enGene Therapeutics Inc is a clinical-stage biotechnology company mainstreaming gene therapy through the delivery of therapeutics to mucosal tissues and other organs, to create new ways to address diseases with high clinical needs. Its pioneering program is detalimogene voraplasmid (also known as detalimogene) for patients with Non-Muscle Invasive Bladder Cancer (NMIBC), a disease with a high clinical burden. Detalimogene is being evaluated in the ongoing multi-cohort LEGEND Phase 2 trial, which includes a pivotal cohort studying detalimogene in high-risk, Bacillus Calmette-Guerin (BCG)-unresponsive patients with carcinoma in situ (CIS) with or without concomitant papillary disease. It is developed using enGene's proprietary Dually Derivatized Oligochitosan (DDX) platform.

About MAMA Mama's Creations Inc.

Mama's Creations Inc manufactures and markets fresh deli-prepared foods distributed through grocery, mass, club, and convenience stores across the United States. Its product portfolio includes refrigerated prepared foods such as meatballs, meatloaf, sausage products, and pasta and rice entrees. The products are principally sold to supermarkets, club chains, mass-market retailers, and food distributors. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.

Share on Social Networks: